Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![Mufaso7 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::984787662656688128.png) Mufaso [@Mufaso7](/creator/twitter/Mufaso7) on x 3235 followers
Created: 2025-07-20 10:46:32 UTC

Lots of evidence that GLP1's have positive effects beyond Obesity/T2D.  Importantly, it sure seems like whenever there is a study evaluating other indications, dual agonist GLP1/GIP wins every time vs mono agonist GLP1.  🤔 Here is a link to a recent study on Parkinson's:  
$LLY $VKTX


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946884424026493064/c:line.svg)

**Related Topics**
[$lly](/topic/$lly)
[eli lilly](/topic/eli-lilly)
[stocks healthcare](/topic/stocks-healthcare)
[$vktx](/topic/$vktx)

[Post Link](https://x.com/Mufaso7/status/1946884424026493064)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Mufaso7 Avatar Mufaso @Mufaso7 on x 3235 followers Created: 2025-07-20 10:46:32 UTC

Lots of evidence that GLP1's have positive effects beyond Obesity/T2D. Importantly, it sure seems like whenever there is a study evaluating other indications, dual agonist GLP1/GIP wins every time vs mono agonist GLP1. 🤔 Here is a link to a recent study on Parkinson's:
$LLY $VKTX

XXXXX engagements

Engagements Line Chart

Related Topics $lly eli lilly stocks healthcare $vktx

Post Link

post/tweet::1946884424026493064
/post/tweet::1946884424026493064